Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis.
about
Amphetamine, past and present--a pharmacological and clinical perspectiveAmphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescentsComparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials.An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorderUpdate on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine.Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorderEfficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners' Parent Rating Scale-revised: Short Form.The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-aLisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.Psychopharmacology of ADHD in pediatrics: current advances and issues.Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study.The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
P2860
Q22241826-DE69F4DA-B453-4BAB-B05D-AC692C039E66Q24186168-8942A7B0-7656-4F92-9C36-B57787D6FC88Q27692676-C127766D-0CD5-4925-AC95-6C22BB5CDD6EQ28246274-CD63A412-DC0A-46E2-9391-C24ED9229B80Q33571016-325A7CD2-3B33-4C11-9CCD-D494ACFCB988Q33782856-FDC01933-8CDE-43D3-BFD8-8BC044F08DA8Q34371046-19843312-C1B8-4E25-BA95-81E5F1A613A0Q35132674-4C839221-211D-4302-B8E4-ED1C40C849F9Q37561623-2BF28922-6801-4904-8B1A-F9344267C3F2Q37568899-DE694CC2-CA45-48FA-90FF-61EF7289D7B2Q41528514-4F05750D-965B-453D-A816-B3CC192F94ACQ42739125-8D1AAFF5-5B97-4C05-A36C-A7DA26075A65Q48236410-60D81F05-B82D-4E67-9032-9170F737B405
P2860
Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effect of lisdexamfetamine dim ...... isorder: a secondary analysis.
@en
Effect of lisdexamfetamine dim ...... isorder: a secondary analysis.
@nl
type
label
Effect of lisdexamfetamine dim ...... isorder: a secondary analysis.
@en
Effect of lisdexamfetamine dim ...... isorder: a secondary analysis.
@nl
prefLabel
Effect of lisdexamfetamine dim ...... isorder: a secondary analysis.
@en
Effect of lisdexamfetamine dim ...... isorder: a secondary analysis.
@nl
P2093
P2860
P356
P1476
Effect of lisdexamfetamine dim ...... isorder: a secondary analysis.
@en
P2093
Frank A Lopez
Lawrence D Ginsberg
Valerie Arnold
P2860
P304
P356
10.3810/PGM.2008.09.1910
P407
P577
2008-09-01T00:00:00Z